Age: 78.0
Sex: F
Vaccine: COVID19-2, FLU4, RSV, COVID19-2, FLUX, RSV
Symptoms: Nerve conduction studies, Nerve conduction studies abnormal, Neuralgia, Pain, Pain in extremity
Clinical narrative: Inability to stand; pain mainly in lower extremities/pain in my feet; Guillain-barre syndrome; Arthralgia; Gait inability/I eventually with PT (physical therapy) was able to walk; losing my ability to coordinate my arms; Fatigue; Nerve conduction studies abnormal; shooting pain in my legs/my entire body was in severe, constant pain; Nerve pain in my fingers, hands and wrists; numbness, tingling and pain in my feet; numbness, tingling and pain in my feet; This is a spontaneous report received from a Consumer or other non HCP from Regulatory Authority. Regulatory number: 2772468-1 (FDA/VAERS Number).  A 78-year-old female patient (not pregnant) received rsv vaccine prot.subunit pref 2v (ABRYSVO), on 06Oct2023 at 11:00 as dose number unknown, single (Batch/Lot number: unknown) at the age of 78 years intramuscular, in left arm for immunisation; davesomeran, elasomeran (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)), on 06Oct2023 at 11:00 as dose number unknown, single) intramuscular, in right arm for covid-19 immunisation; influenza vaccine (INFLUENZA), on 06Oct2023 at 11:00 as dose number unknown, single) intramuscular, in right arm for immunisation. The patient's relevant medical history included: "arthritis" (unspecified if ongoing); "spondylosis lumbar spine" (unspecified if ongoing); "stenosis of the spine" (unspecified if ongoing); "Known allergies: sulfa" (unspecified if ongoing); "Spinal Laminectomy", start date: 04Oct2023 (unspecified if ongoing); "I was sent to Rehab", start date: 16Nov2023, stop date: Dec2023. Concomitant medication(s) included: AMBIEN. Past drug history included: Conjugated estrogens, reaction(s): "Known allergies: conjugated estrogens"; Codeine, reaction(s): "Known allergies: codeine". The following information was reported: ARTHRALGIA (non-serious) with onset 03Nov2023 at 10:00, outcome "not recovered"; FATIGUE (non-serious) with onset 03Nov2023 at 10:00, outcome "not recovered"; GAIT INABILITY (non-serious) with onset 03Nov2023 at 10:00, outcome "not recovered", described as "Gait inability/I eventually with PT (physical therapy) was able to walk"; GUILLAIN-BARRE SYNDROME (hospitalization, medically significant) with onset 03Nov2023 at 10:00, outcome "not recovered"; DYSSTASIA (hospitalization) with onset 03Nov2023 at 10:00, outcome "not recovered", described as "Inability to stand"; NERVE CONDUCTION STUDIES ABNORMAL (non-serious) with onset 03Nov2023 at 10:00, outcome "not recovered"; NEURALGIA (non-serious) with onset 03Nov2023 at 10:00, outcome "not recovered", described as "Nerve pain in my fingers, hands and wrists"; COORDINATION ABNORMAL (non-serious) with onset 03Nov2023 at 10:00, outcome "not recovered", described as "losing my ability to coordinate my arms"; HYPOAESTHESIA (non-serious), PARAESTHESIA (non-serious) all with onset 03Nov2023 at 10:00, outcome "not recovered" and all described as "numbness, tingling and pain in my feet"; PAIN IN EXTREMITY (hospitalization) with onset 03Nov2023 at 10:00, outcome "not recovered", described as "pain mainly in lower extremities/pain in my feet"; PAIN (non-serious) with onset 03Nov2023 at 10:00, outcome "not recovered", described as "shooting pain in my legs/my entire body was in severe, constant pain". The patient was hospitalized for dysstasia, pain in extremity (start date: 04Nov2023); for guillain-barre syndrome (start date: 09Nov2023). The event "guillain-barre syndrome" required physician office visit. The event "pain mainly in lower extremities/pain in my feet" required emergency room visit. The patient underwent the following laboratory tests and procedures: Blood test: Unknown results; Computerised tomogram: Unknown results; Magnetic resonance imaging: Guillain Barre Syndrome, notes: Multiple MRIs and they could not determine a diagnosis, but considered Guillain Barre Syndrome; Nerve conduction studies: Abnormal, notes: nerve conduction tests determined I had medical issues. nerve conduction tests determined I had medical issues; X-ray: Normal, notes: Neurology team did x-rays, etc., and laminectomy looked good. Therapeutic measures were taken as a result of dysstasia. Clinical course: On 03Nov2023, went to ER Hospital, with serious pain mainly in lower extremities. Sent home. 04Nov2023 admitted to Hospital, with excruciating pain and inability to stand. (Had had Spinal Laminectomy on 04Oct2023 at facility.) Neurology team did x-rays, etc., and laminectomy looked good. Multiple MRIs and they could not determine a diagnosis, but considered Guillain Barre Syndrome so sent (name withheld) hospital neurology (they have an immunologist in their neurology group) for assessment) on 09Nov2023. By then I was losing my ability to coordinate my arms, my entire body was in severe, constant pain. They did multiple tests and diagnosed me with GBS when the nerves exiting my spinal column "lit up" and nerve conduction tests determined I had medical issues. On 16Nov2023 I was sent to Rehab Hospital in where I stayed until Dec2023. I eventually with PT (physical therapy) was able to walk and gained most of my other functions back. Is till have nerve pain in my fingers, hands and wrists. I have numbness, tingling and pain in my feet, sometime shooting pain in my legs. I suffer from fatigue. Pain is more difficult at night."  No follow-up attempts are possible. Batch/lot number is not provided, and it cannot be obtained.  Follow-up (30Oct2024): This is a spontaneous follow-up report received from same consumer via -FDA (VAERS ID: 2772468-1).  Updated information: Patient's race captured. Age at Vaccination captured, Pregnant at Time of Vaccination captured and pregnant captured as no. Vaccination Facility details captured, Time captured in vaccination start date and event onset time captured in all events. Dosage captured in Con-med.  No follow-up attempts are possible. Batch/lot number is not provided, and it cannot be obtained.